• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Amazon Alexa Devices Can Now Answer Medication-Related Questions

by Fred Pennic 03/05/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Amazon Alexa Devices Can Now Answer Medication-Related Questions

What You Need to Know:

– In a new collaboration between First Databank and Amazon, consumers will have access to a wide variety of FDB’s drug information through simple queries via Alexa, Amazon’s cloud-based voice service.

– A subset of FDB’s drug information, trusted for more than 40 years by healthcare professionals, can now be accessed by consumers from any Alexa-enabled device.

– The Amazon Alexa integration provides custom content that allows consumers to ask about a drug’s effects such as drug interactions, side effects, precautions, and the drug’s class.


In a new collaboration between First Databank and Amazon, consumers will have access to a wide variety of FDB’s drug information through simple queries via Alexa, Amazon’s cloud-based voice service. As part of the integration, Amazon will be able to deliver valuable medication information from FDB—about drug side effects, uses, and more—to consumers who pose their questions to Alexa from the comfort of their homes. This marks the first time that consumers will have instant access to this breadth and depth of drug information via a voice-enabled service—and it’s another sign of the times as tech giants continue to forge partnerships with health IT companies to better respond to today’s consumer-driven healthcare market.

Specialized Answers about Medication Information

This initiative will leverage concise, clinical drug information authored specifically for Alexa by FDB clinicians, based on their review of the most relevant content from the company’s proprietary consumer drug information monographs. Additionally, the project provides custom content that allows consumers to ask about a drug’s effects such as drug interactions, side effects, precautions, and the drug’s class. The custom data file will provide information for Alexa customers in both English and Spanish and will be updated on a regular basis.

Alexa Common Medication-Related Queries

Some common medication-related queries that Alexa will now answer for consumers by tapping into FDB drug knowledge include:

– “Alexa, what is Tylenol?”

– “Alexa, what type of drug is ibuprofen?”

– “Alexa, what are the side effects of sertraline?”

– “Alexa, what is aspirin used for?

– “Alexa, does Zoloft interact with Aleve?”

– “Alexa, is Advil safe for pregnant women?

– “Alexa, what’s the difference between Tylenol and Advil?

Impact of Partnership Between FDB and Amazon

“We are thrilled to be working closely with Amazon on this unique consumer use of our drug knowledge,” said Bob Katter, president, FDB. “We are proud to bring this essential component of our drug databases directly to consumers through Amazon’s now-ubiquitous and helpful voice-activated technology.”

Katter added: “People lead busy lives and voice provides a simple way to get helpful information about medications including side effects and drug interactions – for themselves and the people they care for – and this information will complement advice from their medical and pharmacy teams. Ultimately, we believe that more informed consumers will lead to improved medication adherence, the reduction of adverse drug events, and better patient outcomes.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Amazon, Amazon Alexa, cloud, First Databank, Health IT, medication, Medication Adherence, Pharmacy

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |